Event Registration
Upcoming Event:
May 5, 2026, 1:00 PM ET (New York)
(Convert this to your time zone)
Summary
This event will focus on how Biotech companies and research institutes can accelerate therapeutic antibody discovery by improving the quality and diversity of its starting candidates. Attendees will learn how modern transgenic mouse platforms—specifically the Atlas™ Antibody Discovery platform—can reduce downstream engineering, expand human antibody diversity, and streamline early discovery workflows. Through performance data, practical guidance, and expert insights, the session will illustrate how better in vivo starting points can directly reduce program risk and failure rates.
Whether you’re exploring new technologies to strengthen your pipeline or preparing to evaluate platforms for licensing, this session will provide actionable insights, technical clarity, and the opportunity to ask detailed questions that inform your next steps. The goal is to equip teams with knowledge that shortens timelines, increases confidence in early leads, and supports more efficient, successful antibody development.
Paste the last sentence in the description before the webinar bullets here. Example: "Join us as we discuss:"
*NSG is a registered trademark in the USA and other countries
JAX® Webinars are complimentary.
No fees will be charged for registering.
Webinars are 45-50 minutes long, followed by a Q&A session.
